Prenatal Diagnosis of Apert Syndrome

Wendy F. Hansen, Asha Rijhsinghani, Stanley Grant, Jerome Yankowitz

Research output: Contribution to journalArticlepeer-review

16 Scopus citations

Abstract

Objective: The role of the human fibroblast growth factor receptor (FGFR) gene family in current prenatal diagnosis and management of craniosynostosis syndromes and skeletal dysplasias is discussed. Method: We present the antenatal ultrasound findings, diagnosis, and management of 2 cases of Apert syndrome before and after molecular prenatal diagnosis was available. Results and Conclusion: Discovery of mutations in FGFR genes now allows the definitive antenatal diagnosis of Apert syndrome, other craniosynostosis syndromes, and skeletal dysplasias.

Original languageEnglish
Pages (from-to)127-130
Number of pages4
JournalFetal Diagnosis and Therapy
Volume19
Issue number2
DOIs
StatePublished - 2004

Keywords

  • Apert syndrome
  • Craniosynostosis
  • Fibroblast growth factor receptor-2
  • Syndactyly

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Embryology
  • Radiology Nuclear Medicine and imaging
  • Obstetrics and Gynecology

Fingerprint

Dive into the research topics of 'Prenatal Diagnosis of Apert Syndrome'. Together they form a unique fingerprint.

Cite this